A new approach to the treatment of sepsis relies on the infusion of mesenchymal stem cells, multipotent cells used experimentally to treat a range of medical conditions. In mouse models, the cells seem to reprogram immune cells that can contribute to sepsis (pages 42–49).
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Immunomodulatory effects of mesenchymal stem cell-conditioned media on lipopolysaccharide of Vibrio cholerae as a vaccine candidate
Stem Cell Research & Therapy Open Access 03 November 2021
-
The bone marrow niche components are adversely affected in sepsis
Molecular Biomedicine Open Access 20 October 2020
-
BMSCs pre-treatment ameliorates inflammation-related tissue destruction in LPS-induced rat DIC model
Cell Death & Disease Open Access 03 October 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Friedenstein, A.J., Petrakova, K.V., Kurolesova, A.I. & Frolova, G.P. Transplantation 6, 230–247 (1968).
Németh, K. et al. Nat Med. 15, 42–49 (2009).
Horwitz, E.M. et al. Cytotherapy 7, 393–395 (2005).
Kidd, S. et al. Cytotherapy 10, 657–667 (2008).
Uccelli, A., Moretta, L. & Pistoia, V. Nat. Rev. Immunol. 8, 726–736 (2008).
Glennie, S., Soeiro, I., Dyson, P.J., Lam, E.W. & Dazzi, F. Blood 105, 2821–2827 (2005).
Raffaghello, L. et al. Stem Cells 26, 151–162 (2008).
Le Blanc, K. et al. Lancet 363, 1439–1441 (2004).
Wynn, R.F. et al. Blood 104, 2643–2645 (2004).
Bocelli-Tyndall, C. et al. J. Cell. Physiol. 209, 732–734 (2006).
Rittirsch, D., Flierl, M.A. & Ward, P.A. Nat. Rev. Immunol. 8, 776–787 (2008).
Horwitz, E.M. et al. Blood 97, 1227–1231 (2001).
Harizi, H. & Gualde, N. Cell Mol. Immunol. 3, 271–277 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tyndall, A., Pistoia, V. Mesenchymal stem cells combat sepsis. Nat Med 15, 18–20 (2009). https://doi.org/10.1038/nm0109-18
Issue Date:
DOI: https://doi.org/10.1038/nm0109-18
This article is cited by
-
Activated mesenchymal stem cells increase drug susceptibility of methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa
Folia Microbiologica (2024)
-
Immunomodulatory effects of mesenchymal stem cell-conditioned media on lipopolysaccharide of Vibrio cholerae as a vaccine candidate
Stem Cell Research & Therapy (2021)
-
The bone marrow niche components are adversely affected in sepsis
Molecular Biomedicine (2020)
-
BMSCs pre-treatment ameliorates inflammation-related tissue destruction in LPS-induced rat DIC model
Cell Death & Disease (2018)
-
Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival in sepsis
Stem Cell Research & Therapy (2015)
